Navigation program: comparison of diagnosis-treatment times among breast cancer patients
DOI:
https://doi.org/10.1590/1518-8345.8049.4847Keywords:
Nursing; Patient Navigation; Medical Oncology; Breast Cancer; Time-to-Treatment; Nurse’s Role.Abstract
Objective: to compare diagnostic-treatment time indicators for care provided to women with breast cancer, according to inclusion in a nursing navigation program. Method: retrospective cohort study conducted at a large hospital. Patients with breast cancer, navigated (n=133) or not (n=226), were included. Sociodemographic and clinical variables were analyzed, and the times (in days) from diagnosis to the start of different treatment modalities constituted the dependent variables. Descriptive and inferential analysis was performed at a significance level of 5%. Results: patients covered by the Unified Health System had significantly shorter median times between diagnosis and any treatment (77.0) and neoadjuvant chemotherapy (77.0) (p-value < 0.001) than those not covered (100.5 and 112.2, respectively). Patients navigated by supplementary health insurance also had shorter access times to both treatment in general (38.0 versus 47.0; p-value <0.001) and neoadjuvant chemotherapy (31.0 versus 50.0; p-value <0.001). Without considering the health insurance plan, no significant differences were found. Conclusion: the navigation program had a positive impact on the accessibility of breast cancer diagnosis and treatment. Investment in this type of care management promoted by nurses is recommended, with greater emphasis on the Unified Health System.
Downloads
References
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Revista Latino-Americana de Enfermagem
This work is licensed under a Creative Commons Attribution 4.0 International License.
RLAE’s authorship concept is based on the substantial contribution by each of the individuals listed as authors, mainly in terms of conceiving and planning the research project, collecting or analyzing and interpreting data, writing and critical review. Indication of authors’ names under the article title is limited to six. If more, authors are listed on the online submission form under Acknowledgements. The possibility of including more than six authors will only be examined on multicenter studies, considering the explanations presented by the authors.Including names of authors whose contribution does not fit into the above criteria cannot be justified. Those names can be included in the Acknowledgements section.
Authors are fully responsible for the concepts disseminated in their manuscripts, which do not necessarily reflect the editors’ and editorial board’s opinion.
